DLD Asset Management LP Purchases 175,000 Shares of Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• DLD Asset Management LP increased its stake in Oaktree Acquisition Corp. III Life Sciences (OACC) by 100%, owning 350,000 shares worth approximately $3.58 million as of its latest SEC filing.
• Several other hedge funds have also entered into positions in OACC during the first quarter, with new stakes purchased by firms such as Kepos Capital LP and Mizuho Securities USA LLC, totaling over $4 million in investments.
• The company's share price opened at $10.49 and has fluctuated between a 52-week low of $9.95 and a high of $10.85.

DLD Asset Management LP lifted its stake in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) by 100.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 350,000 shares of the company's stock after purchasing an additional 175,000 shares during the period. DLD Asset Management LP owned approximately 1.56% of Oaktree Acquisition Corp. III Life Sciences worth $3,580,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Goldman Sachs Group Inc. acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the first quarter valued at $5,417,000. Millennium Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth about $4,848,000. Ghisallo Capital Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth about $4,590,000. Linden Advisors LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth about $6,120,000. Finally, Driehaus Capital Management LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth about $9,180,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

NASDAQ:OACC traded down $0.02 during mid-day trading on Wednesday, hitting $10.45. 2,686 shares of the company's stock traded hands, compared to its average volume of 100,942. The firm has a 50 day moving average of $10.44 and a two-hundred day moving average of $10.36. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $9.95 and a 12 month high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.